Optimized Subcutaneous Immunotherapy Reduces Japanese Cedar Pollinosis Symptoms and Mucosal Cells
A longitudinal study reveals that dose-optimized subcutaneous immunotherapy safely reduces seasonal symptoms, metachromatic cells, and eosinophils in Japanese cedar pollinosis.




